The Fellow on Call: The Heme/Onc Podcast cover image

Episode 045: Myeloma Series, Pt.6- Myeloma Treatment in Transplant Ineligible Patients

The Fellow on Call: The Heme/Onc Podcast

00:00

VRD or DARA-RD for Transplant Ineligible Myeloma Patients

I think we've definitely come a very long way in how we approach our myeloma patients, from what started out initially as very nonspecific chemotherapy cytotoxic agents to then realizing that there were more targeted approaches. It's just almost interesting that we're now slowly moving in the other direction. There are still some questions out there as to what the best combinations are going to be. But I think in the transplant ineligible setting, we do have a lot of good options for upfront therapy.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app